Mike Briggs obtained his PhD at the MRC Clinical Research Centre, Harrow, studying the genetic basis of Osteogenesis Imperfecta. He undertook postdoctoral work at UCLA identifying the genetic basis of chondrodysplasias. In 1996 Mike moved to Manchester as an AR-UK Fellow to continue studying disease mechanisms in chondrodysplasia. In 2004 he was awarded a Wellcome Trust Senior Research Fellowship that was renewed in 2009. In 2012 he was appointed Professor of Skeletal Genetics in the Institute of Genetic Medicine at Newcastle University and continues to work on disease mechanisms in chondrodysplasia with a focus on identifying novel therapeutics for these rare diseases. Mike has been instrumental in establishing several European consortia for the diagnosis and research of rare skeletal diseases. These have included European Skeletal Dysplasia Network, EuroGrow and most recently SYBIL, a large-scale FP7 funded project involving 18 partners over 5 years.